Oxidative stress in the chronic phase after stroke

REFERENCES

• Floyd RA. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 1990; 4: 2587–2597.
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Long DM. The molecular basis of brain injury and brain edema: the role of oxygen free radicals. Neurosurgery 1990; 27: 1–11.
   PubMed Web of Science ®Google Scholar
• Kitagava K, Matsumoto M, Kimura K, Kamata T. Cerebrovascular diseases and free radicals. Jpn J Circ 1989; 25: 354–362.
   Google Scholar
• Hallenbeck J. Cytokines, macrophages, and leukocytes in brain ischemia. Neurology 1997; 49: S5–S9.
   Web of Science ®Google Scholar
• Alexandrova ML, Bochev PG, Markova VI et al. Changes in phagocyte activity in patients with ischaemic stroke. Luminescence 2001; 16: 1–9.
   PubMedGoogle Scholar
• Grau AJ, Berger E. Granulocyte adhesion, deformability, and superoxide formation in acute stroke. Stroke 1992; 23: 33–39.
   PubMed Web of Science ®Google Scholar
• Imre S, Fekete I, Farkas T. Increased proportion of decosahexanoic acid and high lipid peroxidation capacity in erythrocytes of stroke patients. Stroke 1994; 25: 2416–2420.
   PubMed Web of Science ®Google Scholar
• Gruener N, Gross B, Gozlan O, Barak M. Increase in superoxide dismutase after cerebral accident. Life Sci 1994; 54: 711–713.
   PubMed Web of Science ®Google Scholar
• Spranger M, Krempien S, Schwab S, Donnenberg S, Hacke W. Superoxide dismutase activity in serum of patients with acute cerebral ischemic injury. Correlation with clinical course and infarct size. Stroke 1997; 28: 2425–2428.
   PubMed Web of Science ®Google Scholar
• Yagi K. Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337–351.
   PubMed Web of Science ®Google Scholar
• van Kooten F, Giabattoni G, Koudstaal PJ et al. Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. Stroke 1999; 30: 546–549.
   PubMed Web of Science ®Google Scholar
• van Swieten J, Koudstaal P. Visser M et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604–607.
   PubMed Web of Science ®Google Scholar
• Brown G, Silver G, Reiff J et al. Polymorphonuclear neutrophil chemiluminescence in whole blood from blunt trauma patients with multiple injuries. J Trauma 1999; 46: 297–305.
   PubMedGoogle Scholar
• Chan S, Monteiro H, Deucher G et al. Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects. Free Radic Biol Med 1997; 24: 1411–1418.
   Web of Science ®Google Scholar
• Bochev P. Bechev B, Magrisso M. Six-sample multiplexing computerized analyzer for integral and spectral luminescence measurements. Anal Chim Acta 1992; 256: 29–32.
   Web of Science ®Google Scholar
• Walan A, Dahlgren C, Kihlstrom E et al. Phagocyte killing of Campylobacter jejuni in relation to oxidative activation. Pat hol Microbiol Immunol Scand 1992; 100: 424–430.
   PubMed Web of Science ®Google Scholar
• Bechev B, Magrisso M, Bochev Pet al. Dependence of whole blood luminol chemiluminescence on PMNL and RBC count. J Biochem Biophys Methods 1993; 27: 301–309.
   PubMedGoogle Scholar
• Maral J, Puget K, Michoelsn A. Comparative study of superoxide dismutase, catalase and glutathione peroxidase levels in erythrocytes of different animals. Biochem Biophys Res Commun 1977; 77: 1525–1535.
   PubMed Web of Science ®Google Scholar
• Sigma Chemie Catalog, 1996; 235.
   Google Scholar
• Pereslegina I. Salivary antioxidant enzymes activity in normal children. Lab Delo 1989; 11: 20–23.
   PubMedGoogle Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70–77.
   PubMed Web of Science ®Google Scholar
• Asakawa T, Matsushita S. Thiobarbituric acid test for detecting lipid peroxides. Lipids 1980; 14: 401–406.
   Web of Science ®Google Scholar
• Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367–1379.
   PubMed Web of Science ®Google Scholar
• Zweier JL, Kuppusamy P. Lutty GA. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues. Proc Natl Acad Sci USA 1988; 85: 4066–4070.
   PubMedGoogle Scholar
• Kochanek PM, Nemoto EM, Evans RW, Schoettle RJ. Polymorphonuclear leukocytes, platelets, and lipid mediators in the pathogenesis of ischemic and traumatic central nervous system injury. New Trends Lipid Mediators Res 1990; 4: 220–240.
   Google Scholar
• Elneihoum AM, Falke P. Axels son L, Lundberg E, Lindgarde F, Ohlsson K. Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke 1996; 27: 1734–1738.
   PubMed Web of Science ®Google Scholar
• Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA 1988; 85: 9748–9752.
   PubMed Web of Science ®Google Scholar
• Key Ns, Platt JL, Vercellotti M. Vascular endothelial cell proteoglycans are susceptible to cleavage by neutrophils. Arterioscler Thromb 1992; 12: 836–842.
   PubMedGoogle Scholar
• Wieland E, Brandes A, Armstrong VW, Oelleich M. Oxidative modification of low density lipoproteins by human polymorphonuclear leukocytes. Eur J Clin Chem Clin Biochem 1993; 31: 725–731.
   PubMedGoogle Scholar
• Yagi K. Assay for serum lipid peroxide level and its clinical significance. In: Yagi K. (ed) Lipid Peroxides in Biology and Medicine. Orlando, FL: Academic Press, 1982; 223–243.
   Google Scholar
• Goldstein LB, Adams R, Becker K et al. AHA Scientific Statement. Primary prevention of ischemic stroke. A statement for healthcare professionals from the stroke council of the American Heart Association. Circulation 2001; 103: 163.
   PubMed Web of Science ®Google Scholar
• Fassbender K, Mossner R, Motsch L, Kischka U, Grau A, Hennerici M. Circulating selectin- and immunoglobulin-type adhesion molecules in acute ischemic stroke. Stroke 1995; 26: 1361–1364.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–126.
   PubMed Web of Science ®Google Scholar
• Langlois M, Duprez D, Delanghe J, Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001; 103: 1863.
   PubMed Web of Science ®Google Scholar
• Kurl S, Tuomainen TP, Laukkanen JA et al. Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 2002; 33: 1568.
   PubMed Web of Science ®Google Scholar
• Grotta JC, Alexandrov AV. Is preventing microemboli enough? Circulation 2001; 103: 2321.
   PubMed Web of Science ®Google Scholar
• D'Agostino RB, Wolf PA, Belanger AJ et al. Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study. Stroke 1994; 25: 40–43.
   PubMed Web of Science ®Google Scholar
• Lilius EM, Mamila P. Photon emission of phagocytes in relation to stress and disease. Experientia 1992; 48: 1082–1091.
   PubMedGoogle Scholar
• Kontos H. Oxygen radicals in cerebral vascular injury. Circ Res 1985; 57: 508–516.
   PubMed Web of Science ®Google Scholar
• Benson RT, Sacco RL. Stroke prevention: hypertension, diabetes, tobacco, and lipids. Neurol Clin 2000; 18: 309–319.
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264.
   PubMed Web of Science ®Google Scholar
• Gillum RF, Sempos CT. The end of the long-term decline in stroke mortality in the United States? Stroke 1997; 28: 1527-1529.
   Google Scholar